Skip to main content

Becton Dickinson and Company (BDX-N) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 275.30
Day High 278.43
Open:277.72
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Global Women's Health Diagnostics Market, Forecast to 2025 - Leading Players are General Electric; Abbott Labs; Siemens; Becton, Dickinson & Co; and Quest Diagnostics
- GlobeNewswire - Tue Jan 14, 6:33AM CST
GlobeNewswire - CMTX
Tue Jan 14, 6:33AM CST
The "Global Women Health Diagnostics Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
LongueVue Capital Adds Experienced Healthcare Operating Partners to Support New & Existing Investments
- PR Newswire - Fri Jan 10, 7:00AM CST
PR Newswire - CMTX
Fri Jan 10, 7:00AM CST
LongueVue Capital Partners ("LVC"), a partnership-driven, operator-centric private equity firm based in New Orleans with approximately $500 million of assets under management, announced today that Geoff Glass and Pete Allen have joined the firm as healthcare Operating Partners. Geoff, a seasoned pharma services executive, will focus on the life science space. Pete, a healthcare executive with broad reaching experience, will focus on medical devices and related contract services as well as healthcare supply chain services. The additions of both Pete and Geoff reiterate LVC's commitment to the healthcare industry, which is one of the firm's largest investment verticals.
LongueVue Capital Adds Experienced Healthcare Operating Partners to Support New & Existing Investments
- PR Newswire - Fri Jan 10, 7:00AM CST
PR Newswire - PRNW
Fri Jan 10, 7:00AM CST
NEW ORLEANS , Jan. 10, 2020 /PRNewswire/ -- LongueVue Capital Partners ("LVC"), a partnership-driven, operator-centric private equity firm based in New Orleans with approximately $500 million of assets under management, announced today that Geoff Glass and Pete Allen have joined the firm as healthcare Operating Partners. Geoff, a seasoned pharma services executive, will focus on the life science space. Pete, a healthcare executive with broad reaching experience, will focus on medical devices and related contract services as well as healthcare supply chain services. The additions of both Pete and Geoff reiterate LVC's commitment to the healthcare industry, which is one of the firm's largest investment verticals.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 266.06 +4.14% increase
on 12/18/19
Period Open:269.03
Price movement based on the high, low and last over the given period.
279.62 -0.91% decrease
on 01/15/20
+8.05 (+2.99%) increase
since 12/17/19
3-Month 240.61 +15.16% increase
on 11/13/19
Period Open:256.80
Price movement based on the high, low and last over the given period.
279.62 -0.91% decrease
on 01/15/20
+20.28 (+7.90%) increase
since 10/17/19
52-Week 221.47 +25.11% increase
on 05/15/19
Period Open:236.11
Price movement based on the high, low and last over the given period.
279.62 -0.91% decrease
on 01/15/20
+40.97 (+17.35%) increase
since 01/17/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies